WallStreetZenWallStreetZen

NASDAQ: GNTA
Genenta Science Spa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their GNTA stock forecasts and price targets.

Forecast return on equity

Is GNTA forecast to generate an efficient return?

Company
-73.48%
Industry
70.31%
Market
361.81%
GNTA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GNTA forecast to generate an efficient return on assets?

Company
-41.3%
Industry
22.47%
GNTA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GNTA earnings per share forecast

What is GNTA's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.47
Avg 2 year Forecast
-$0.54

GNTA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GNTA$0.88N/AN/A
AKTX$0.23$1.30+457.94%Strong Buy
LNAI$0.71N/AN/A
ITRM$0.31N/AN/A
NNVC$0.96N/AN/A
View Top Biotech Stocks

Genenta Science Spa Stock Forecast FAQ

What is GNTA's earnings growth forecast for 2026-2027?

(NASDAQ: GNTA) Genenta Science Spa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 186.58%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,291.05%.

Genenta Science Spa's earnings in 2026 is -$10,116,946.On average, 3 Wall Street analysts forecast GNTA's earnings for 2026 to be -$8,983,523, with the lowest GNTA earnings forecast at -$8,631,228, and the highest GNTA earnings forecast at -$9,247,744.

In 2027, GNTA is forecast to generate -$10,350,581 in earnings, with the lowest earnings forecast at -$9,944,675 and the highest earnings forecast at -$10,655,009.

If you're new to stock investing, here's how to buy Genenta Science Spa stock.

What is GNTA's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: GNTA) forecast ROE is -73.48%, which is considered weak.

What is GNTA's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: GNTA) Genenta Science Spa's current Earnings Per Share (EPS) is -$0.55. On average, analysts forecast that GNTA's EPS will be -$0.47 for 2026, with the lowest EPS forecast at -$0.45, and the highest EPS forecast at -$0.48. In 2027, GNTA's EPS is forecast to hit -$0.54 (min: -$0.52, max: -$0.56).

What is GNTA's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: GNTA) forecast ROA is -41.3%, which is lower than the forecast US Biotechnology industry average of 22.47%.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.